CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-18 | Sterling Louis III Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Sterling Louis III Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | O'Connor Oliver Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | O'Connor Oliver Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | Odysseas Kostas D Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Odysseas Kostas D Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | Horn Keith Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Horn Keith Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | DiPaolo Mark Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | DiPaolo Mark Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | Bonfiglio Patrice Eadon Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Bonfiglio Patrice Eadon Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-02-01 | Berg Aaron EVP, President US | Grant or award · Restricted Stock Unit | +116,000 | 116,000 | ||
| 2024-02-01 | Berg Aaron EVP, President US | Grant or award · Stock Option (right to buy) | +418,000 | 418,000 | ||
| 2024-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Unit | +116,000 | 116,000 | ||
| 2024-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +418,000 | 418,000 | ||
| 2024-02-01 | Reilly Thomas Charles EVP and CFO | Grant or award · Restricted Stock Unit | +116,000 | 116,000 | ||
| 2024-02-01 | Reilly Thomas Charles EVP and CFO | Grant or award · Stock Option (right to buy) | +418,000 | 418,000 | ||
| 2024-01-31 | Berg Aaron EVP, President US | Option exercise | +34,567 | 629,149 | ||
| 2024-01-31 | Berg Aaron EVP, President US | Shares withheld for taxes | −18,868 | $1.24 | $23K | 610,281 |
Page 10 of 67 · 1,339 trades